Pages that link to "Q64959554"

The following pages link to Facioscapulohumeral muscular dystrophy: epidemiological and molecular study in a north-east Italian population sample. (Q64959554):

Displaying 39 items.

• Facioscapulohumeral dystrophy: the path to consensus on pathophysiology (Q21195884) (← links)
• Facioscapulohumeral muscular dystrophy: consequences of chromatin relaxation (Q26998289) (← links)
• Targeting mRNA for the treatment of facioscapulohumeral muscular dystrophy (Q28069201) (← links)
• SORBS2 transcription is activated by telomere position effect-over long distance upon telomere shortening in muscle cells from patients with facioscapulohumeral dystrophy (Q30009101) (← links)
• Facioscapulohumeral Dystrophy (Q30250223) (← links)
• Patient-identified disease burden in facioscapulohumeral muscular dystrophy (Q30583657) (← links)
• Prevalence of genetic muscle disease in Northern England: in-depth analysis of a muscle clinic population (Q33685609) (← links)
• Restrictive lung involvement in facioscapulohumeral muscular dystrophy (Q34079666) (← links)
• Large-scale population analysis challenges the current criteria for the molecular diagnosis of fascioscapulohumeral muscular dystrophy (Q34266481) (← links)
• Reachable workspace in facioscapulohumeral muscular dystrophy (FSHD) by Kinect (Q34517198) (← links)
• Facioscapulohumeral Muscular Dystrophy: More Complex than it Appears (Q34685919) (← links)
• Low penetrance in facioscapulohumeral muscular dystrophy type 1 with large pathological D4Z4 alleles: a cross-sectional multicenter study (Q35061314) (← links)
• Multiplex Screen of Serum Biomarkers in Facioscapulohumeral Muscular Dystrophy (Q35094699) (← links)
• FHL1 reduces dystrophy in transgenic mice overexpressing FSHD muscular dystrophy region gene 1 (FRG1). (Q35103393) (← links)
• Muscle Quantitative MR Imaging and Clustering Analysis in Patients with Facioscapulohumeral Muscular Dystrophy Type 1 (Q35693421) (← links)
• Atypical onset in a series of 122 cases with FacioScapuloHumeral Muscular Dystrophy (Q35859588) (← links)
• Muscle pathology grade for facioscapulohumeral muscular dystrophy biopsies (Q35988817) (← links)
• Reachable workspace reflects dynamometer-measured upper extremity strength in facioscapulohumeral muscular dystrophy (Q36073192) (← links)
• Segregation between SMCHD1 mutation, D4Z4 hypomethylation and Facio-Scapulo-Humeral Dystrophy: a case report (Q36135207) (← links)
• Transcriptional profiling in facioscapulohumeral muscular dystrophy to identify candidate biomarkers. (Q36342987) (← links)
• Clinical expression of facioscapulohumeral muscular dystrophy in carriers of 1-3 D4Z4 reduced alleles: experience of the FSHD Italian National Registry (Q36472254) (← links)
• Diagnostic approach for FSHD revisited: SMCHD1 mutations cause FSHD2 and act as modifiers of disease severity in FSHD1 (Q36695157) (← links)
• Reevaluating measures of disease progression in facioscapulohumeral muscular dystrophy (Q36698443) (← links)
• Telomere position effect regulates DUX4 in human facioscapulohumeral muscular dystrophy (Q37013579) (← links)
• Design, set-up and utility of the UK facioscapulohumeral muscular dystrophy patient registry (Q37056729) (← links)
• Large scale genotype-phenotype analyses indicate that novel prognostic tools are required for families with facioscapulohumeral muscular dystrophy (Q37256202) (← links)
• A Systematic Review and Meta-analysis on the Epidemiology of the Muscular Dystrophies (Q38703274) (← links)
• Medication adherence in patients with myotonic dystrophy and facioscapulohumeral muscular dystrophy (Q38812196) (← links)
• Chronic pain has a strong impact on quality of life in facioscapulohumeral muscular dystrophy (Q48153881) (← links)
• Facioscapulohumeral dystrophy: Activating an early embryonic transcriptional program in human skeletal muscle. (Q52714812) (← links)
• The French National Registry of patients with Facioscapulohumeral muscular dystrophy (Q59526149) (← links)
• A multinational study on motor function in early-onset FSHD (Q59876196) (← links)
• Genotype-phenotype correlations in FSHD (Q64096947) (← links)
• Facioscapulohumeral muscular dystrophy (Q87411200) (← links)
• Myoediting: Toward Prevention of Muscular Dystrophy by Therapeutic Genome Editing (Q88540277) (← links)
• Protein kinase A activation inhibits DUX4 gene expression in myotubes from patients with facioscapulohumeral muscular dystrophy (Q89093839) (← links)
• Does DNA Methylation Matter in FSHD? (Q89976236) (← links)
• G-quadruplex ligands mediate downregulation of DUX4 expression (Q90391205) (← links)
• Type 1 FSHD with 6-10 Repeated Units: Factors Underlying Severity in Index Cases and Disease Penetrance in Their Relatives Attention (Q90632425) (← links)